Oncological Outcomes of Nerve-Sparing Radical Hysterectomy for
Cervical Cancer: A Systematic Review

J 2015

Oncological Outcomes of Nerve-Sparing Radical Hysterectomy for Cervical Cancer: A Systematic Review

BASARAN, Derman, Ladislav DUŠEK, Ondřej MÁJEK a David CIBULA

Základní údaje

Originální název

Oncological Outcomes of Nerve-Sparing Radical Hysterectomy for Cervical Cancer: A Systematic Review

Autoři

BASARAN, Derman (792 Turecko), Ladislav DUŠEK (203 Česká republika, garant, domácí), Ondřej MÁJEK (203 Česká republika, domácí) a David CIBULA (203 Česká republika)

Vydání

Annals of Surgical Oncology, New York, Springer, 2015, 1068-9265

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30200 3.2 Clinical medicine

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 3.655

Kód RIV

RIV/00216224:14110/15:00083872

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1245/s10434-015-4377-7

UT WoS

000359425000033

Klíčová slova anglicky

cancer adjuvant therapy; cancer recurrence; follow up; human; intermethod comparison; nerve sparing radical hysterectomy; nuclear magnetic resonance imaging; outcome assessment; radical hysterectomy; Review; systematic review; uterine cervix cancer

Štítky

EL OK

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 17. 9. 2015 15:02, Soňa Böhmová

Anotace

V originále

This study aimed to review the oncologic outcomes of nerve-sparing radical hysterectomy (NSRH) in cervical cancer and to compare them with those of standard conventional radical hysterectomy (CRH). A search of the MEDLINE (Ovid), EMBASE (Ovid), and Cochrane Central Register of Controlled Trials (CENTRAL) databases for studies published to March 3, 2014 was performed using the search term "nerve sparing or radical hysterectomy and cervical cancer." The main outcome measure was the recurrence rate after NSRH. The hazard ratio for recurrence was used to compare NSRH and CRH. A total of 21 studies reported data on oncologic outcomes of NSRH. The recurrence rate after NSRH was reported to be 0 to 19.6 %. Of the 21 studies, 10 comparing outcomes between NSRH and CRH were assessed for their eligibility to be included in a meta-analysis. However, the scarcity and heterogeneity of effect estimates in these comparison trials precluded performance of a meta-analysis. The results showed that the evidence addressing the oncologic safety of NSRH over that of CRH in cervical cancer is neither adequate nor statistically relevant. A properly designed, prospective randomized noninferiority trial is needed to assess the oncologic outcomes of NSRH before this surgical approach is adopted as the standard of care for patients with tumors that have unfavorable prognostic features. Until then, NSRH should be considered primarily for patients with small tumors due to the very low risk of parametrial and lymph node involvement, with maximum benefit conferred to the patient from autonomic nerve preservation without any requirement for adjuvant treatment.

Citovat

BASARAN, Derman, Ladislav DUŠEK, Ondřej MÁJEK a David CIBULA. Oncological Outcomes of Nerve-Sparing Radical Hysterectomy for Cervical Cancer: A Systematic Review. Annals of Surgical Oncology. New York: Springer, 2015, roč. 22, č. 9, s. 3033-3040. ISSN 1068-9265. Dostupné z: https://dx.doi.org/10.1245/s10434-015-4377-7.

@article{1311261,
   author = {Basaran, Derman and Dušek, Ladislav and Májek, Ondřej and Cibula, David},
   article_location = {New York},
   article_number = {9},
   doi = {http://dx.doi.org/10.1245/s10434-015-4377-7},
   keywords = {cancer adjuvant therapy; cancer recurrence; follow up; human; intermethod comparison; nerve sparing radical hysterectomy; nuclear magnetic resonance imaging; outcome assessment; radical hysterectomy; Review; systematic review; uterine cervix cancer},
   language = {eng},
   issn = {1068-9265},
   journal = {Annals of Surgical Oncology},
   title = {Oncological Outcomes of Nerve-Sparing Radical Hysterectomy for Cervical Cancer: A Systematic Review},
   volume = {22},
   year = {2015}
}

TY  - JOUR
ID  - 1311261
AU  - Basaran, Derman - Dušek, Ladislav - Májek, Ondřej - Cibula, David
PY  - 2015
TI  - Oncological Outcomes of Nerve-Sparing Radical Hysterectomy for Cervical Cancer: A Systematic Review
JF  - Annals of Surgical Oncology
VL  - 22
IS  - 9
SP  - 3033-3040
EP  - 3033-3040
PB  - Springer
SN  - 10689265
KW  - cancer adjuvant therapy
KW  - cancer recurrence
KW  - follow up
KW  - human
KW  - intermethod comparison
KW  - nerve sparing radical hysterectomy
KW  - nuclear magnetic resonance imaging
KW  - outcome assessment
KW  - radical hysterectomy
KW  - Review
KW  - systematic review
KW  - uterine cervix cancer
N2  - This study aimed to review the oncologic outcomes of nerve-sparing radical hysterectomy (NSRH) in cervical cancer and to compare them with those of standard conventional radical hysterectomy (CRH). A search of the MEDLINE (Ovid), EMBASE (Ovid), and Cochrane Central Register of Controlled Trials (CENTRAL) databases for studies published to March 3, 2014 was performed using the search term "nerve sparing or radical hysterectomy and cervical cancer." The main outcome measure was the recurrence rate after NSRH. The hazard ratio for recurrence was used to compare NSRH and CRH. A total of 21 studies reported data on oncologic outcomes of NSRH. The recurrence rate after NSRH was reported to be 0 to 19.6 %. Of the 21 studies, 10 comparing outcomes between NSRH and CRH were assessed for their eligibility to be included in a meta-analysis. However, the scarcity and heterogeneity of effect estimates in these comparison trials precluded performance of a meta-analysis. The results showed that the evidence addressing the oncologic safety of NSRH over that of CRH in cervical cancer is neither adequate nor statistically relevant. A properly designed, prospective randomized noninferiority trial is needed to assess the oncologic outcomes of NSRH before this surgical approach is adopted as the standard of care for patients with tumors that have unfavorable prognostic features. Until then, NSRH should be considered primarily for patients with small tumors due to the very low risk of parametrial and lymph node involvement, with maximum benefit conferred to the patient from autonomic nerve preservation without any requirement for adjuvant treatment.
ER  -

BASARAN, Derman, Ladislav DUŠEK, Ondřej MÁJEK a David CIBULA. Oncological Outcomes of Nerve-Sparing Radical Hysterectomy for Cervical Cancer: A Systematic Review. \textit{Annals of Surgical Oncology}. New York: Springer, 2015, roč.~22, č.~9, s.~3033-3040. ISSN~1068-9265. Dostupné z: https://dx.doi.org/10.1245/s10434-015-4377-7.

Podrobný výpis o publikaci